DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.

ABSTRACT: BACKGROUND:Cannabis withdrawal syndrome (CWS) was newly added to the Diagnostic and Statistical Manual of Mental Disorders in its most recent edition, DSM-5. With cannabis use increasing among U.S. adults, information is needed about the prevalence and correlates of DSM-5 CWS in the general population. This study presents nationally representative findings on the prevalence, sociodemographic and clinical correlates of DSM-5 CWS among U.S. adults. METHOD:Participants ?18 years were interviewed in the National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III) in 2012-2013. Among the sub-sample of frequent cannabis users in the prior 12 months (?3 times a week; N?=?1527), the prevalence and demographic and clinical correlates of DSM-5 CWS were examined. RESULTS:In frequent cannabis users, the prevalence of CWS was 12.1%. The most common withdrawal symptoms among those with CWS were nervousness/anxiety (76.3%), hostility (71.9%), sleep difficulty (68.2%) and depressed mood (58.9%). CWS was associated with significant disability (p?

SUBMITTER: Livne O 

PROVIDER: S-EPMC6359953 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature